- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Zealand Pharma A/S (ZELA)
Zealand Pharma A/S stock price live, this page displays CSE ZELA stock exchange data. View the ZELA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Zealand Pharma A/S real time stock price chart below.
What Is the Zealand Pharma A/S Stock Price Today?
The Zealand Pharma A/S stock price today is 367.50.
What Is the Stock Symbol for Zealand Pharma A/S?
The stock symbol for Zealand Pharma A/S is ""ZELA.""
What Stock Exchange Does Zealand Pharma A/S Trade On?
Zealand Pharma A/S is listed and trades on the Copenhagen stock exchange.
Is Zealand Pharma A/S a Good Stock to Buy?
Determining whether Zealand Pharma A/S—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ZELA quote. (ISIN: DK0060257814)
What Is the Zealand Pharma A/S Stock Price Today?
The Zealand Pharma A/S stock price today is 367.50.
What Is the Stock Symbol for Zealand Pharma A/S?
The stock symbol for Zealand Pharma A/S is ""ZELA.""
What Stock Exchange Does Zealand Pharma A/S Trade On?
Zealand Pharma A/S is listed and trades on the Copenhagen stock exchange.
Is Zealand Pharma A/S a Good Stock to Buy?
Determining whether Zealand Pharma A/S—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ZELA quote. (ISIN: DK0060257814)
367.40
+17.00(+4.85%)
Real-time Data·
Fair Value
An estimate of a Zealand Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
350.40
369.80
52 wk Range
306.10
965.00
ZELA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
ZELA is included in our AI-picked strategies. See how they work
Fair Value
An estimate of a Zealand Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
350.40369.80
52 wk Range
306.10965.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ZELA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Zealand Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
829.06
Upside
+125.66%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Zealand Pharma A/S Company Profile
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. It also provides Zegalogue, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon for treating congenital hyperinsulinism. In addition, the company developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. Zealand Pharma A/S was incorporated in 1997 and is based in Søborg, Denmark.
Compare ZELA to Peers and Sector
Metrics to compare | ZELA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipZELAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −20.4x | −1.6x | −0.5x | |
PEG Ratio | 0.55 | −0.35 | 0.00 | |
Price/Book | 2.9x | 1.8x | 2.6x | |
Price / LTM Sales | 434.6x | 5.5x | 3.3x | |
Upside (Analyst Target) | 138.3% | 38.9% | 40.6% | |
Fair Value Upside | Unlock | 14.1% | 5.3% | Unlock |
Analyst Ratings
15 Buy
2 Hold
0 Sell
Ratings:
17 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 829.06
(+125.66% Upside)
Earnings
Latest Release
May 08, 2025
EPS / Forecast
-4.75 / -2.19
Revenue / Forecast
8.09M / 20.52M
People Also Watch
FAQ
What Stock Exchange Does Zealand Pharma Trade On?
Zealand Pharma is listed and trades on the Copenhagen Stock Exchange stock exchange.
What Is the Stock Symbol for Zealand Pharma?
The stock symbol for Zealand Pharma is "ZELA."
What Is the Zealand Pharma Market Cap?
As of today, Zealand Pharma market cap is 25.94B.
What Is Zealand Pharma's Earnings Per Share (TTM)?
The Zealand Pharma EPS (TTM) is 94.49.
When Is the Next Zealand Pharma Earnings Date?
Zealand Pharma will release its next earnings report on 12 Nov 2025.
From a Technical Analysis Perspective, Is ZELA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Zealand Pharma Stock Split?
Zealand Pharma has split 0 times.
How Many Employees Does Zealand Pharma Have?
Zealand Pharma has 385 employees.
What is the current trading status of Zealand Pharma (ZELA)?
As of 15 Aug 2025, Zealand Pharma (ZELA) is trading at a price of 367.40, with a previous close of 350.40. The stock has fluctuated within a day range of 350.40 to 369.80, while its 52-week range spans from 306.10 to 965.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.